Between January 2005 and December 2006, a higher incidence of paratyphoid fever (53.8%) compared to typhoid fever (44.9%) has been observed at a tertiary hospital in South India. A definite seasonal pattern of incidence is seen in paratyphoid fever (peak incidence during October–December, i.e., post monsoon period) but not in typhoid fever. Decreased fluoroquinolone susceptibility is much higher in S. Paratyphi A (98.8%) as compared to S. Typhi (46.5%). These findings are of importance in therapeutic decision making, development of vaccination strategies and implementing public health measures for disease control.
Get full access to this article
View all access options for this article.
References
1.
CrumpJA, YoussefFG, LubySP, Estimating the incidence of typhoid fever and other febrile illnesses in developing countries. Emerg Infect Dis2003;9:539–44
2.
HerikstadH, MotarjemiY, TauxeRV. Salmonella surveillance: a global survey of public health serotyping. Epidemiol Infect2002;129:1–8
3.
PalitA, GhoshS, DuttaS, SurD, BhattacharyaMK, BhattacharyaSK. Increasing prevalence of Salmonella enterica serotype Paratyphi-A in patients with enteric fever in a periurban slum setting of Kolkata, India. Int J Environ Health Res2006;16:455–9
4.
PadmapriyaV, KennethJ, AmarnathSK. Re-emergence of Salmonella paratyphi A: a shift in immunity?Natl Med J India2003;16:47–8
5.
HarishBN, MenezesGA, SarangapaniK, ParijaSC. Fluoroquinolone resistance among Salmonella enterica serovar Paratyphi A in Pondicherry. Indian J Med Res2006;124:585–7
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 15th Informational Supplement M100-S15. Wayne, PA, USA: Clinical and Laboratory Standards Institute, 2005
8.
VollaardAM, AliS, van AstenHA, Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA2004;291:2607–15
9.
HakanenA, KotilainenP, JalavaJ, SiitonenA, HuovinenP. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol1999;37:3572–7
10.
KadhiravanT, WigN, KapilA, KabraSK, RenukaK, MisraA. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis2005;5:37
